Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management.
The San Francisco-based company, which launched its weight-loss program in December, said users will now have access to generic and 503B compounded injectable medications and oral medication kits...
MediSecure, a provider of a digital prescription platform, is the latest in Australia to fall victim to a major ransomware attack by unidentified actors.
On Thursday, 16 May, the company reported a cyber attack "impacting the personal and health information of individuals" in its system. The company's website and phone lines have since gone offline.
"While we continue to gather more information...
OpenAI and Moderna announced the pair have expanded their partnership to offer the pharma giant's employees access to ChatGPT Enterprise, a platform that allows customizable GPTs to be developed for a specific purpose.
Through ChatGPT Enterprise, users can create GPTs by beginning a conversation with ChatGPT, then providing extra knowledge on a subject or giving it instructions. Users can also...
Xaira Therapeutics, an AI-enabled drug discovery and development company, announced its launch with more than $1 billion in capital.
The biotechnology company is a joint incubation by ARCH Venture Partners and Foresite Labs, the lead investors in the funding round.
Lux Capital, Two Sigma Ventures, F-Prime, Rsquared, SV Angel, Menlo Ventures, Sequoia Capital, NEA, the Parker Institute for...
It has become increasingly necessary for healthcare executives to monitor the pharmaceutical supply chain, primarily as overdose deaths related to counterfeit pill use more than doubled from July-Sept. 2019 to Oct.-Dec. 2021, according to the CDC.
The FDA sought to address the issue by enacting the Drug Supply Chain Security Act (DSCSA), which went into effect in November. Still, healthcare...
Ohio-based Redi Health, a tech-enabled health management platform for patients and healthcare providers, announced it closed a $14 million Series B funding round led by Blue Heron Capital.
North Coast Ventures participated in the round alongside existing investors Mutual Capital Partners, Rev1 Ventures, M25 and Refinery Ventures.
WHAT IT DOES
Redi Health offers a patient-facing mobile app and...
Publicly listed Daewoong Pharmaceutical has recently unveiled its AI-driven drug development system, powered by a database of hundreds of millions of pre-processed compounds.
WHAT IT'S ABOUT
Over the past two years, researchers of the Seoul-based pharma giant have sought to solve perennial issues in the development of novel drugs, particularly high cost and low efficiency.
Serving as the...
Waltz Health, a digital search engine for prescription pricing and reimbursement, announced its move into the Medicare market.
The Chicago-based company will provide health plans supporting Medicare beneficiaries in accessing lower prescription drug prices via its Marketplace Search technology, an AI-enabled search engine that health organizations can give their consumers that utilizes data from...
French startup Bioptimus, which aims to create an AI foundation model for biology to drive research and innovation, announced its launch with $35 million in seed funding.
Sofinnova Partners led the round, with support from Bpifrance Large Venture, Frst and multistage VC Cathay Innovation.
Hummingbird, Headline, Owkin, NJF Capital, Top Harvest Capital, and tech entrepreneur Xavier Niel also...
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup, TenAces.
TenAces will utilize AI, integrating biology and machine learning algorithms, to discover molecular glue therapies to enhance targeted protein degradation.
Molecular glues are protein-binding small molecules that change two protein...
